rss
Ann Rheum Dis 2009;68:1208-1212 doi:10.1136/ard.2008.095257
  • Basic and translational research

Quantitative assessment of antibodies to ribonucleoproteins in primary Sjögren syndrome: correlation with B-cell biomarkers and disease activity

  1. S Candon1,2,
  2. J E Gottenberg3,
  3. D Bengoufa4,
  4. L Chatenoud1,2,
  5. X Mariette3
  1. 1
    INSERM U580, Hôpital Necker-Enfants Malades, Paris, France
  2. 2
    Université Paris Descartes, Faculté de Médecine René Descartes, Paris, France
  3. 3
    Rhumatologie, Institut Pour la Santé et la Recherche Médicale (INSERM) U802, Université Paris-Sud 11, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris (AP-HP), Le Kremlin Bicêtre, Bicêtre, France
  4. 4
    Immunologie et Histocompatibilité, Hôpital Saint-Louis, AP-HP, Paris, France
  1. Professor X Mariette, Service de Rhumatologie, Hôpital de Bicêtre, 78 rue du Général Leclerc, 94275 Le Kremlin Bicêtre, Bicêtre, France; xavier.mariette{at}bct.ap-hop-paris.fr
  • Accepted 26 July 2008
  • Published Online First 19 August 2008

Abstract

Objectives: To assess the added value of using a radioligand assay (RLA) compared with ELISA to detect antibodies to SSA, SSB and RNP, and to analyse the correlation between autoantibody levels, B-cell biomarkers and disease activity.

Patients and methods: Antibodies to SSA, SSB and RNP were assessed in 127 patients with primary Sjögren syndrome (pSS) using an RLA and ELISA. In parallel, measures of B-cell activation were determined including serum levels of B-cell-activating factor of the tumour necrosis factor family or BLyS (BAFF).

Results: RLA was more sensitive than ELISA for the detection of antibodies to SSB (54% of positive samples versus 37%, respectively) and antibodies to RNP (9% vs 3%). No difference was seen for the sensitivity of detection of antibodies to SSA. Anti-SSA and anti-SSB levels were correlated with both techniques. Mean levels of antibodies to SSA were significantly higher in patients presenting antibodies to both SSA and SSB than in those exhibiting antibodies to SSA only (RLA: mean (SEM) anti-SSA levels 2343 (158) cpm vs 1348 (286) cpm, respectively, p = 0.02; ELISA: 6.8 (0.8) vs 3.8 (0.4), respectively, p = 0.003). Levels of antibodies to SSA and SSB significantly correlated with those of circulating BAFF (r = 0.4, p = 0.004 and r = 0.6, p<0.001, respectively) and with B-cell biomarkers, including levels of gammaglobulins, β2 microglobulin and rheumatoid factor.

Conclusion: RLA allowed a quantitative and more sensitive detection of antibodies to SSB and RNP in pSS. Quantitative assessment of autoantibodies might disclose a biomarker of disease activity and enable further insight into the pathogenesis of the spreading of the autoantibody response.

Footnotes

  • *SC and JEG contributed equally to the work.

  • Competing interests: None.

  • Ethics approval: Obtained.

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. All versions of this article:
    1. ard.2008.095257v1
    2. 68/7/1208 most recent

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.